EP 1553914 A2 20050720 - NOVEL COSMETIC FORMULATIONS BASED ON A GEL-FORMING AND/OR THICKENING AGENT AND APPLICATIONS OF SAME
Title (en)
NOVEL COSMETIC FORMULATIONS BASED ON A GEL-FORMING AND/OR THICKENING AGENT AND APPLICATIONS OF SAME
Title (de)
KOSMETISCHE FORMULIERUNGEN AUF BASIS VON GELBILDNERN UND/ODER VERDICKERN UND DEREN VERWENDUNG
Title (fr)
NOUVELLES FORMULATIONS COSMETIQUES A BASE D'UN AGENT GELIFIANT ET/OU EPAISSISSANT ET LEURS APPLICATIONS
Publication
Application
Priority
- FR 0302898 W 20031002
- FR 0212202 A 20021002
Abstract (en)
[origin: WO2004030605A2] The invention relates to the field of essential goods and, in particular, the field of cosmetics, hygiene and dermopharmaceutics. More specifically, the invention relates to aqueous, fluid or gel cosmetic compositions which are intended to be applied to the skin, mucous membranes or teguments. The inventive compositions are characterised in that they contain, by way of an active principle, a gel-forming and/or thickening agent which is formed by a combination of three components, namely: (i) an ammonium acrylate and polyacrylamide copolymer and/or an anionic acrylic copolymer, (ii) lecithins or phospholipids of plant origin and (iii) a polyglyceryl acylate, together with or mixed with excipients suitable for topical use. Said compositions can comprise other active principles suitable for use in cosmetics. The invention also relates to the use of the inventive compositions in cosmetics or dermopharmaceutics for the production of emulsions, gels or creams which are perfectly stable.
IPC 1-7
IPC 8 full level
A61K 8/04 (2006.01); A61K 8/39 (2006.01); A61K 8/55 (2006.01); A61K 8/81 (2006.01); A61P 17/00 (2006.01); A61Q 19/00 (2006.01); B01J 13/00 (2006.01); C09K 23/00 (2022.01); A61Q 1/02 (2006.01); A61Q 5/12 (2006.01); A61Q 17/04 (2006.01); A61Q 19/02 (2006.01); A61Q 19/06 (2006.01); A61Q 19/08 (2006.01)
CPC (source: EP US)
A61K 8/042 (2013.01 - EP US); A61K 8/39 (2013.01 - EP US); A61K 8/553 (2013.01 - EP US); A61K 8/8158 (2013.01 - EP US); A61P 17/00 (2017.12 - EP); A61Q 19/00 (2013.01 - EP US); B01J 13/0056 (2013.01 - EP US); B01J 13/0065 (2013.01 - EP US); C09K 23/017 (2022.01 - EP US); A61Q 1/02 (2013.01 - EP US); A61Q 5/12 (2013.01 - EP US); A61Q 17/04 (2013.01 - EP US); A61Q 19/005 (2013.01 - EP US); A61Q 19/02 (2013.01 - EP US); A61Q 19/06 (2013.01 - EP US); A61Q 19/08 (2013.01 - EP US)
Citation (search report)
See references of WO 2004030605A2
Citation (examination)
EP 1566179 A2 20050824 - MERZ PHARMA GMBH & CO KGAA [DE]
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004030605 A2 20040415; WO 2004030605 A3 20040521; AU 2003283489 A1 20040423; AU 2003283489 A8 20040423; EP 1553914 A2 20050720; FR 2845287 A1 20040409; FR 2845287 B1 20070817; US 2006153792 A1 20060713
DOCDB simple family (application)
FR 0302898 W 20031002; AU 2003283489 A 20031002; EP 03775463 A 20031002; FR 0212202 A 20021002; US 53008205 A 20051208